| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications
|
Xiao, Xin
|
|
2018
|
63 |
C |
p. 61-70
|
artikel
|
| 2 |
Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics
|
Christopoulos, Panagiotis F.
|
|
2018
|
63 |
C |
p. 79-95
|
artikel
|
| 3 |
A systematic review of the effectiveness of patient-based educational interventions to improve cancer-related pain
|
Oldenmenger, Wendy H.
|
|
2018
|
63 |
C |
p. 96-103
|
artikel
|
| 4 |
Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium
|
Clement, S.C.
|
|
2018
|
63 |
C |
p. 28-39
|
artikel
|
| 5 |
Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment
|
D'Uva, Gabriele
|
|
2018
|
63 |
C |
p. 1-18
|
artikel
|
| 6 |
Cancer immunotherapy in a neglected population: The current use and future of T-cell-mediated checkpoint inhibitors in organ transplant patients
|
Chae, Young Kwang
|
|
2018
|
63 |
C |
p. 116-121
|
artikel
|
| 7 |
Checkpoint inhibitors in breast cancer – Current status
|
Polk, Anne
|
|
2018
|
63 |
C |
p. 122-134
|
artikel
|
| 8 |
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
|
Tokunaga, Ryuma
|
|
2018
|
63 |
C |
p. 40-47
|
artikel
|
| 9 |
Editorial Board
|
|
|
2018
|
63 |
C |
p. ii
|
artikel
|
| 10 |
Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs
|
Coppola, Carmela
|
|
2018
|
63 |
C |
p. 135-143
|
artikel
|
| 11 |
Multi-agent chemotherapy in advanced soft tissue sarcoma (STS) – A systematic review and meta-analysis
|
Zer, Alona
|
|
2018
|
63 |
C |
p. 71-78
|
artikel
|
| 12 |
Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer
|
Başaran, Gül A.
|
|
2018
|
63 |
C |
p. 144-155
|
artikel
|
| 13 |
Proton therapy for locally advanced breast cancer: A systematic review of the literature
|
Kammerer, Emmanuel
|
|
2018
|
63 |
C |
p. 19-27
|
artikel
|
| 14 |
Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation
|
Ferris, Robert L.
|
|
2018
|
63 |
C |
p. 48-60
|
artikel
|
| 15 |
Staging and surgical approaches in gastric cancer: A systematic review
|
Coburn, Natalie
|
|
2018
|
63 |
C |
p. 104-115
|
artikel
|
| 16 |
The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision
|
Roselló, Susana
|
|
2018
|
63 |
C |
p. 156-171
|
artikel
|
Tijdschrift beschrijving